>_ QFI Terminal
TerminalStocks › GCTK

GlucoTrack, Inc. (GCTK) Stock

Healthcare · Medical - Instruments & Supplies · IL
$2.50 -1.96%
Last updated Sep 20, 2026 15:00 UTC

GCTK Key Statistics

Market Cap$1.42M
P/E (TTM)-0.05
P/S (TTM)
P/B (TTM)0.80
Revenue (TTM)$0.00
EPS (TTM)$-49.16
Dividend Yield
ROE (TTM)-393.33%
Net Margin0.00%
Gross Margin0.00%
52W High$13.50
52W Low$0.29
Analyst View
Price Target
Employees11
Volume7,539

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

CEO: Paul V. Goode. Company website

GCTK — Frequently Asked Questions

What is the GCTK stock price today?

GlucoTrack, Inc. (GCTK) trades at $2.50, down 1.96% on the day, as of Sep 20, 2026 15:00 UTC.

What is GlucoTrack, Inc.'s market cap?

GlucoTrack, Inc. has a market capitalisation of $1.42M, calculated from the live GCTK share price and shares outstanding.

What is the P/E ratio of GCTK?

GCTK has no meaningful price-to-earnings ratio: GlucoTrack, Inc. lost $49.16 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does GlucoTrack, Inc. make?

GlucoTrack, Inc. generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for GCTK?

GCTK has traded between $0.29 and $13.50 over the past 52 weeks, and the last price is 81.5% below that high.

Is GlucoTrack, Inc. profitable?

Yes. GlucoTrack, Inc. keeps 0.00% of revenue as net income over the trailing twelve months.

What sector is GlucoTrack, Inc. in?

GlucoTrack, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in IL .

Who is the CEO of GlucoTrack, Inc.?

Paul V. Goode is the chief executive of GlucoTrack, Inc., which employs 11 people.

Where can I track GCTK in real time?

QFI Terminal shows GCTK with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See GCTK live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open GCTK in Terminal See plans

Medical - Instruments & Supplies stocks

MDLN Medline Inc. BDX Becton, Dickinson and Company BAX Baxter International Inc. ISRG Intuitive Surgical, Inc. SOLV Solventum Corporation AVTR Avantor, Inc. RMD ResMed Inc. COO The Cooper Companies, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.